{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:46:29Z","timestamp":1772732789359,"version":"3.50.1"},"reference-count":78,"publisher":"Informa UK Limited","issue":"17","funder":[{"name":"not been funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1080\/14656566.2018.1527905","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T10:37:58Z","timestamp":1537871878000},"page":"1867-1874","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Pharmacological treatment of anxiety disorders in adults with epilepsy"],"prefix":"10.1080","volume":"19","author":[{"given":"Marco","family":"Mula","sequence":"first","affiliation":[{"name":",","place":["UK"]},{"name":",","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,10]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.3\/bbandelow"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61455-X"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.03.020"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114525674"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01222.x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00612.x"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02927.x"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03500.x"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000431"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.10.010"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318245f461"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23601"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.47003.x"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.05.021"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00956.x"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01893.x"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2012.03586.x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.11.012"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.10.023"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.07.027"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.01.006"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2003.5.3\/jprice"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2009.05.004"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-014-0807-8"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356427"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0b013e318059361a"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2011.04.064"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.15.4.450"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12832"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.4.365"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.2.182"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00475.x"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2009.02276.x"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2014.12.002"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2018.04.010"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.04.005"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2016.02.015"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0355-2"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00679.x"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-5050(02)00045-8"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2008.10.007"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2013.09.011"},{"key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1684\/epd.2008.0184","article-title":"Ictal fear depends on the cerebral laterality of the epileptic activity","volume":"10","author":"Guimond A","year":"2008","unstructured":"Guimond A, Braun CMJ, B\u00e9langer E, et al. Ictal fear depends on the cerebral laterality of the epileptic activity. Epileptic Disord Int Epilepsy J Videotape. 2008;10:101\u2013112.","journal-title":"Epileptic Disord Int Epilepsy J Videotape"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.5.771"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0084-7"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000113763.11862.26"},{"key":"e_1_3_4_49_1","unstructured":"Generalised anxiety disorder and panic disorder in adults: management | Guidance and guidelines | NICE n.d. (cited 2018 Jul 9. Available from: https:\/\/www.nice.org.uk\/guidance\/cg113"},{"key":"e_1_3_4_50_1","unstructured":"Post-traumatic stress disorder: management | Guidance and guidelines | NICE n.d. (cited 2018 Jul 9. Available from: https:\/\/www.nice.org.uk\/guidance\/cg26."},{"key":"e_1_3_4_51_1","unstructured":"Obsessive-compulsive disorder and body dysmorphic disorder: treatment | Guidance and guidelines | NICE n.d. (cited 2018 Jul 9. Available from: https:\/\/www.nice.org.uk\/guidance\/cg31"},{"key":"e_1_3_4_52_1","unstructured":"Social anxiety disorder: recognition assessment and treatment | Guidance and guidelines | NICE n.d. (cited 2018 Jul 9 Available from: https:\/\/www.nice.org.uk\/guidance\/cg159"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710001434"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711000800"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200524030-00013"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000119"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0062-9"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318184ff5b"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.02.017"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2008.01.004"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006115"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20151022-01"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052964"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-012-1804-7"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03276.x"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12101"},{"key":"e_1_3_4_67_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1684\/epd.2016.0837","article-title":"Using anxiolytics in epilepsy: neurobiological, neuropharmacological and clinical aspects","volume":"18","author":"Mula M","year":"2016","unstructured":"Mula M. Using anxiolytics in epilepsy: neurobiological, neuropharmacological and clinical aspects. Epileptic Disord Int Epilepsy J Videotape. 2016;18:217\u2013227.","journal-title":"Epileptic Disord Int Epilepsy J Videotape"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01089.x"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.03.022"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.02.014"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.6.4.575"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2012.10.009"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.09.023"},{"key":"e_1_3_4_74_1","first-page":"43","article-title":"[Pharmacotherapy for social phobia, generalised anxiety disorder and separation anxiety disorder in children and adolescents: an overview]","volume":"50","author":"Dieleman GC","year":"2008","unstructured":"Dieleman GC, Ferdinand RF. [Pharmacotherapy for social phobia, generalised anxiety disorder and separation anxiety disorder in children and adolescents: an overview]. Tijdschr Voor Psychiatr. 2008;50:43\u201353.","journal-title":"Tijdschr Voor Psychiatr"},{"key":"e_1_3_4_75_1","first-page":"CD004851","article-title":"Newer generation antidepressants for depressive disorders in children and adolescents","volume":"11","author":"Hetrick SE","year":"2012","unstructured":"Hetrick SE, McKenzie JE, Cox GR, et al. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2012;11:CD004851.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-22159-5"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.20653"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31822cfc90"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.12030408"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.03.008"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2018.1527905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:51:11Z","timestamp":1772729471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2018.1527905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":78,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,11,22]]}},"alternative-id":["10.1080\/14656566.2018.1527905"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2018.1527905","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}